Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Microbial-mediated blood-brain barrier development at the intersection of the gut-brain axis

Award Number: R21NS121432
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/30/2021
PERIOD OF PERFORMANCE END DATE: 08/31/2024

Group Awards By:

View Award Description

Microbial-mediated blood-brain barrier development at the intersection of the gut-brain axis - PROJECT SUMMARY/ABSTRACT The blood-brain barrier (BBB) is the direct interface that governs the interaction between the circulating blood and central nervous system (CNS). Current gut-brain axis research has made the association between the gut microbiome and CNS functions but largely bypasses the BBB which determines whether or what microbial mediators will enter CNS to have impacts on brain functions. Another aspect of the potential impacts of these circulating microbial factors is the direct impact on BBB components. Preterm birth represents an increasing burden for healthcare and society due to long term prematurity-associated neurodevelopmental deficits. Morbidities such as sepsis, necrotizing enterocolitis, and perinatal brain injuries are all associated with high risk for poor neurodevelopmental outcomes and have been associated with dysbiosis thus making the neonatal microbiome a target to improve developmental outcomes. In this proposal, we aim to test the overall hypothesis that early dysbiosis associated with preterm birth contributes to compromised blood-brain barrier development and functions, and has long term effects on brain development and neurological outcomes. We will utilize an established gnotobiotic mouse transfaunation method as the experimental platform. Three clinically relevant microbial communities will be utilized to evaluate BBB development under the influence of gut microbiota from prenatal stages to the early postnatal period: 1) Communities from preterm infants with low postnatal growth; 2) Communities from preterm infants born to a mother with confirmed chorioamnionitis; 3) Communities from full term healthy infants. In addition, the combination of Lactobacillus acidophilus and Bifidobacterium infantis will be maternally administrated as a strategy to optimize BBB development and function. BBB integrity, temporal development of BBB tight junction, components and transporter systems with phenotypical markers will be examined. Furthermore, neuronal development and white matter maturation at different developmental stages will be investigated as well as behaviors at a juvenile age. 16S rRNA gene sequencing of fecal samples of human donors, the transfaunated dams and offspring will be used to characterize the microbial communities to determine the distinct microbial species/pattern associated with BBB functional changes. The novel knowledge from this study will be 1) demonstrating that preterm microbial communities can influence BBB development and neurological outcomes from the embryonic stage to the postnatal period; 2) identifying the target(s) within the BBB components where microbial mediators have specific effects; 3) identifying microbial markers associated with BBB development and functions. Furthermore, by testing the efficacy of probiotics in improving microbiome characteristics, BBB function and neurological outcomes, we will identify a microbiome-based therapeutic option that can be used as a potential effective strategy to reduce neurodevelopmental deficits in preterm infants.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2022	UNIVERSITY OF CHICAGO	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	2/7/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $205,000 )
2022	2022	UNIVERSITY OF CHICAGO	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	2	8/25/2022	NON-COMPETING CONTINUATION	$205,000
2022	2021	UNIVERSITY OF CHICAGO	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	7/27/2022	NEW	$0
														Subtotal = $205,000

Issue Date FY: 2021 ( Subtotal = $246,000 )
2021	2021	UNIVERSITY OF CHICAGO, THE	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	9/24/2021	NEW	$246,000
														Subtotal = $246,000

Grand Total All Awards = $451,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Microbial-mediated blood-brain barrier development at the intersection of the gut-brain axis

Award Number: R21NS121432

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/30/2021

PERIOD OF PERFORMANCE END DATE: 08/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer